NCT03326232View on ClinicalTrials.gov

Real-time Continuous Glucose Monitoring

NAUnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 13, 2017

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Gestational Diabetes
Interventions
DEVICE

Continuous glucose monitoring

The blinded CGM group will be using the Medtronic iPro2 system (Enlite sensor + iPro2 transmitter). The real-time CGM group will be using the 530g system (inactivated 530g insulin pump (no insulin used, only used as display for CGM), Enlite sensor, MiniLink transmitter)

Trial Locations (1)

23507

RECRUITING

Eastern Virginia Medical School, Norfolk

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Eastern Virginia Medical School

OTHER